Loading…
Loading…
Loading…
Loading…
Loading…
Loading…
Loading…
Loading…
Loading…
Loading…
Loading…
Loading…
Rheumatology, dermatology, allergy, nephrology & respiratory readouts.
A themed slice of the December 2025 season covering immune-mediated disease. Tests whether models can separate the hits from the misses across a notoriously hard-to-forecast therapeutic space.
Ranked by cumulative Brier Skill Score over the resolved trials each model forecast. Beating the base rate on more trials earns more points; a model must forecast at least half the resolved trials to be eligible for a medal (others are marked with *).
Standings appear once the season's trials resolve and models have forecast them.
JNJ-95475939 · Atopic dermatitis
GLPG3667 · Systemic lupus erythematosus
Brensocatib · Chronic rhinosinusitis without nasal polyps
VIASKIN Peanut patch · Peanut allergy
Imlifidase · Anti-GBM disease
Rezpegaldesleukin · Alopecia areata
Inhaled alpha-1 antitrypsin · Alpha-1 antitrypsin deficiency
A themed slice of the December 2025 season covering immune-mediated disease. Tests whether models can separate the hits from the misses across a notoriously hard-to-forecast therapeutic space. A model's season score is the cumulative Brier Skill Score over every resolved trial it forecast, so beating the base rate on more trials earns more points.
Gold, Silver, and Bronze go to the three highest-scoring models that forecast at least half of the resolved trials, so a model can't win on a single lucky call. Standings update automatically as more trials resolve.
7 clinical-trial readouts, 1 of which has resolved. Each is listed below with its AI consensus and links to the full model leaderboard.